This program was cosupported by educational grants from AbbVie Inc.; Intra-Cellular Therapies; Neurocrine; and Sunovion.
This activity is supported by educational grants from Intra-Cellular Therapies and Sunovion.
NPs and PAs
Discuss the unmet needs in the treatment of schizophrenia
Educate on evidence-based treatments for schizophrenia
Describe the role of nonpharmacologic therapies in schizophrenia
Discuss new innovative treatments for the illness
Individualize treatment choices, giving consideration to efficacy, safety, and long-term data
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Asbach has disclosed that he has received consulting fees from Biogen and Neurocrine Biosciences; and has received fees for non-CME/CE services from AbbVie, Avanir, Johnson & Johnson, Otsuka, and Neurocrine Biosciences.
Dr Cunningham has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 75%.
The estimated time to complete this activity is 1.00 hour.
Release date: January 24, 2022
Expiration date: January 23, 2023
Interactive video lecture
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP course advisor: Patricia Cunningham, DNSc, PMHNP, FNP, Clinical Neuroscience Solutions, Memphis, Tennessee
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 23, 2023. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program has been made available online.